METHOD OF ACHIEVING PERSISTENT TRANSGENE EXPRESSION - Patent 1242608

(19)

(11)

EP 1 242 608 A2

(12)

(88)	Date of publication A3:
	04.04.2002

(43)	Date of publication:
	25.09.2002 Bulletin 2002/39

(21)	Application number: 00991274.2

(22)	Date of filing: 27.12.2000

(51)	International Patent Classification (IPC)⁷: C12N 15/86, A61K 48/00, A61P 19/02, A61P 37/00

(86)	International application number:
	PCT/EP0013/297

(87)	International publication number:
	WO 0104/8231 (05.07.2001 Gazette 2001/27)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

28.12.1999 US 473018

(71)	Applicant: Novartis AG
	4056 Basel (CH)

(72)	Inventors:
	LU, Patrick Rockville, MD 20855 (US) ENNIST, David, Leonard Bethesda, MD 20817 (US) MINA, Mervat Germantown, MD 20874 (US)

(74)	Representative: Gros, Florent
	Novartis AGCorporate Intellectual Property,Patent & Trademark Department CH 4002 Basel 4002 Basel (CH)

(54)	METHOD OF ACHIEVING PERSISTENT TRANSGENE EXPRESSION